Citation: | Luo Zihuan, Sun Qiquan. Research highlights of renal transplantation in 2020: voice from China[J]. ORGAN TRANSPLANTATION, 2021, 12(2): 169-176. doi: 10.3969/j.issn.1674-7445.2021.02.006 |
[1] |
KALANTAR-ZADEH K, LI PK. Strategies to prevent kidney disease and its progression[J]. Nat Rev Nephrol, 2020, 16(3): 129-130. DOI: 10.1038/s41581-020-0253-1.
|
[2] |
KALANTAR-ZADEH K, WIGHTMAN A, LIAO S. Ensuring choice for people with kidney failure-dialysis, supportive care, and hope[J]. N Engl J Med, 2020, 383(2): 99. DOI: 10.1056/NEJMp2001794.
|
[3] |
CHEN N, HAO C, LIU BC, et al. Roxadustat treatment for anemia in patients undergoing long-term dialysis[J]. N Engl J Med, 2019, 381(11): 1011-1022. DOI: 10.1056/NEJMoa1901713.
|
[4] |
LOUPY A, AUBERT O, ORANDI BJ, et al. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study[J]. BMJ, 2019, 366: l4923. DOI: 10.1136/bmj.l4923.
|
[5] |
MAGEE CN, MURAKAMI N, BORGES TJ, et al. Notch-1 inhibition promotes immune regulation in transplantation via regulatory T cell-dependent mechanisms[J]. Circulation, 2019, 140(10): 846-863. DOI: 10.1161/CIRCULATIONAHA.119.040563.
|
[6] |
EVREN E, RINGQVIST E, TRIPATHI KP, et al. Distinct developmental pathways from blood monocytes generate human lung macrophage diversity[J]. Immunity, 2021, 54(2): 259-275. DOI: 10.1016/j.immuni.2021.12.003.
|
[7] |
FERREIRA LMR, MULLER YD, BLUESTONE JA, et al. Next-generation regulatory T cell therapy[J]. Nat Rev Drug Discov, 2019, 18(10): 749-769. DOI: 10.1038/s41573-019-0041-4.
|
[8] |
JORGENSEN AM, YOO JJ, ATALA A. Solid organ bioprinting: strategies to achieve organ function[J]. Chem Rev, 2020, 120(19): 11093-11127. DOI: 10.1021/acs.chemrev.0c00145.
|
[9] |
STEWART BJ, FERDINAND JR, CLATWORTHY MR. Using single-cell technologies to map the human immune system-implications for nephrology[J]. Nat Rev Nephrol, 2020, 16(2): 112-128. DOI: 10.1038/s41581-019-0227-3.
|
[10] |
LIU Y, HU J, LIU D, et al. Single-cell analysis reveals immune landscape in kidneys of patients with chronic transplant rejection[J]. Theranostics, 2020, 10(19): 8851-8862. DOI: 10.7150/thno.48201.
|
[11] |
FERNANDEZ DM, GIANNARELLI C. Mapping transplant arteriosclerosis cell-by-cell: a path to new immune insights[J]. Circ Res, 2020, 127(8): 994-996. DOI: 10.1161/CIRCRESAHA.120.317907.
|
[12] |
MASOUD AG, LIN J, AZAD AK, et al. Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury[J]. J Clin Invest, 2020, 130(1): 94-107. DOI: 10.1172/JCI128469.
|
[13] |
CAI J, DENG J, GU W, et al. Impact of local alloimmunity and recipient cells in transplant arteriosclerosis[J]. Circ Res, 2020, 127(8): 974-993. DOI: 10.1161/CIRCRESAHA.119.316470.
|
[14] |
WANG D, WANG J, BAI L, et al. Long-term expansion of pancreatic islet organoids from resident procr+ progenitors[J]. Cell, 2020, 180(6): 1198-1211. DOI: 10.1016/j.cell.2020.02.048.
|
[15] |
CIPPÀ PE, LIU J, SUN B, et al. A late B lymphocyte action in dysfunctional tissue repair following kidney injury and transplantation[J]. Nat Commun, 2019, 10(1): 1157. DOI: 10.1038/s41467-019-09092-2.
|
[16] |
LIU L, FANG C, FU W, et al. Endothelial cell-derived interleukin-18 released during ischemia reperfusion injury selectively expands T peripheral helper cells to promote alloantibody production[J]. Circulation, 2020, 141(6): 464-478. DOI: 10.1161/CIRCULATIONAHA.119.042501.
|
[17] |
LI X, LIAO J, SU X, et al. Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1[J]. Theranostics, 2020, 10(21): 9561-9578. DOI: 10.7150/thno.42153.
|
[18] |
ZHOU C, ZHOU L, LIU J, et al. Kidney extracellular matrix hydrogel enhances therapeutic potential of adipose-derived mesenchymal stem cells for renal ischemia reperfusion injury[J]. Acta Biomater, 2020, 115: 250-263. DOI: 10.1016/j.actbio.2020.07.056.
|
[19] |
ZHU J, ZHANG G, SONG Z, et al. Protein kinase C-δ mediates kidney tubular injury in cold storageassociated kidney transplantation[J]. J Am Soc Nephrol, 2020, 31(5): 1050-1065. DOI: 10.1681/ASN.2019101060.
|
[20] |
NA N, ZHAO D, ZHANG J, et al. Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/Akt signaling[J]. Signal Transduct Target Ther, 2020, 5(1): 194. DOI: 10.1038/s41392-020-00232-5.
|
[21] |
XU Z, TSAI HI, XIAO Y, et al. Engineering programmed death ligand-1/cytotoxic T-lymphocyte-associated antigen-4 dual-targeting nanovesicles for immunosuppressive therapy in transplantation[J]. ACS Nano, 2020, 14(7): 7959-7969. DOI: 10.1021/acsnano.9b09065.
|
[22] |
WANG Z, JIANG S, LI S, et al. Targeted galectin-7 inhibition with ultrasound microbubble targeted gene therapy as a sole therapy to prevent acute rejection following heart transplantation in a rodent model[J]. Biomaterials, 2020, 263: 120366. DOI: 10.1016/j.biomaterials.2020.120366.
|
[23] |
YI L, CHEN Y, JIN Q, et al. Antagomir-155 attenuates acute cardiac rejection using ultrasound targeted microbubbles destruction[J]. Adv Healthc Mater, 2020, 9(14): e2000189. DOI: 10.1002/adhm.202000189.
|
[24] |
LIAO T, LIU X, REN J, et al. Noninvasive and quantitative measurement of C4d deposition for the diagnosis of antibody-mediated cardiac allograft rejection[J]. EBioMedicine, 2018, 37: 236-245. DOI: 10.1016/j.ebiom.2018.10.061.
|
[25] |
LIAO T, ZHANG Y, REN J, et al. Noninvasive quantification of intrarenal allograft C4d deposition with targeted ultrasound imaging[J]. Am J Transplant, 2019, 19(1): 259-268. DOI: 10.1111/ajt.15105.
|
[26] |
LIAO T, LI Q, ZHANG Y, et al. Precise treatment of acute antibody-mediated cardiac allograft rejection in rats using C4d-targeted microbubbles loaded with nitric oxide[J]. J Heart Lung Transplant, 2020, 39(5): 481-490. DOI: 10.1016/j.healun.2020.02.002.
|
[27] |
LUO Z, LIAO T, ZHANG Y, et al. Triptolide attenuates transplant vasculopathy through multiple pathways[J]. Front Immunol, 2020, 11: 612. DOI: 10.3389/fimmu.2020.00612.
|
[28] |
RODRIGUEZ-RODRIGUEZ AE, DONATE-CORREA J, ROVIRA J, et al. Inhibition of the mTOR pathway: a new mechanism of β cell toxicity induced by tacrolimus[J]. Am J Transplant, 2019, 19(12): 3240-3249. DOI: 10.1111/ajt.15483.
|
[29] |
TRIÑANES J, TEN DIJKE P, GROEN N, et al. Tacrolimus-induced BMP/SMAD signaling associates with metabolic stress-activated Foxo1 to trigger β-cell failure[J]. Diabetes, 2020, 69(2): 193-204. DOI: 10.2337/db19-0828.
|
[30] |
LING Q, HUANG H, HAN Y, et al. The tacrolimusinduced glucose homeostasis imbalance in terms of the liver: from bench to bedside[J]. Am J Transplant, 2020, 20(3): 701-713. DOI: 10.1111/ajt.15665.
|
[31] |
JIAO W, ZHANG Z, XU Y, et al. Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota[J]. Am J Transplant, 2020, 20(9): 2413-2424. DOI: 10.1111/ajt.15880.
|
[32] |
WANG XD, LIU JP, SONG TR, et al. Kidney transplantation from HBsAg+living donors to HBsAgrecipients: clinical outcomes at a high-volume center in China[J]. Clin Infect Dis, 2020: ciaa178. DOI: 10.1093/cid/ciaa178.
|
[33] |
ZHU L, FU C, CHEN S, et al. Successful singlekidney transplantation in adult recipients using pediatric donors aged 8 to 36 months: comparable outcomes with those using pediatric donors aged >3 years[J]. Transplantation, 2019, 103(11): 2388-2396. DOI: 10.1097/TP.0000000000002618.
|
[34] |
HE X, CHEN G, ZHU Z, et al. The first case of ischemiafree kidney transplantation in humans[J]. Front Med (Lausanne), 2019, 6: 276. DOI: 10.3389/fmed.2019.00276.
|
[35] |
HURKMANS DP, VERHOEVEN JGHP, DE LEUR K, et al. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment[J]. J Immunother Cancer, 2019, 7(1): 182. DOI: 10.1186/s40425-019-0653-6.
|
[36] |
XIAO H, GAO F, PANG Q, et al. Diagnostic accuracy of donor-derived cell-free DNA in renal-allograft rejection: a Meta-analysis[J]. Transplantation, 2020, DOI: 10.1097/TP.0000000000003443 [Epub ahead of print].
|
[37] |
CHEN XT, CHEN WF, LI J, et al. Urine donor-derived cell-free DNA helps discriminate BK polyomavirusassociated nephropathy in kidney transplant recipients with BK polyomavirus infection[J]. Front Immunol, 2020, 11: 1763. DOI: 10.3389/fimmu.2020.01763.
|
[38] |
HAN F, WAN S, SUN Q, et al. Donor plasma mitochondrial DNA is correlated with posttransplant renal allograft function[J]. Transplantation, 2019, 103(11): 2347-2358. DOI: 10.1097/TP.0000000000002598.
|
[39] |
ADAM BA, KIKIC Z, WAGNER S, et al. Intragraft gene expression in native kidney BK virus nephropathy versus T cell-mediated rejection: prospects for molecular diagnosis and risk prediction[J]. Am J Transplant, 2020, 20(12): 3486-3501. DOI: 10.1111/ajt.15980.
|
[40] |
LIU Y, ZHOU S, HU J, et al. Characterization of aberrant pathways activation and immune microenviroment of BK virus associated nephropathy[J]. Aging (Albany NY), 2020, 12(14): 14434-14451. DOI: 10.18632/aging.103486.
|
[41] |
HUANG Y, CHEN XT, YANG SC, et al. Detection of proximal tubule involvement by BK polyomavirus in kidney transplant recipients with urinary sediment doubleimmunostaining[J]. Front Immunol, 2020, 11: 582678. DOI: 10.3389/fimmu.2020.582678.
|
[42] |
JIN Y, ZHOU Y, DENG W, et al. Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level[J]. Oncogene, 2021, 40(1): 46-54. DOI: 10.1038/s41388-020-01502-w.
|
[43] |
WANG Y, LIU Y, DENG W, et al. Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing[J]. Oncogene, 2020, 39(35): 5734-5742. DOI: 10.1038/s41388-020-01398-6.
|
[44] |
LOUPY A, AUBERT O, REESE PP, et al. Organ procurement and transplantation during the COVID-19 pandemic[J]. Lancet, 2020, 395(10237): e95-e96. DOI: 10.1016/S0140-6736(20)31040-0.
|
[45] |
陈伟, 黄美近. 新型冠状病毒肺炎疫情下实施外科手术的思考和建议[J]. 中山大学学报(医学科学版), 2020, 41(2): 180-183. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK202002003.htm
CHEN W, HUANG MJ. Thoughts and advices on performing procedures in surgery during the outbreak of novel coronavirus pneumonia[J]. J Sun Yat-sen Univ (Med Sci), 2020, 41(2): 180-183. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK202002003.htm
|
[46] |
WANG J, LI X, CAO G, et al.COVID-19 in a kidney transplant patient[J].Eur Urol, 2020, 77(6): 769-770.DOI: 10.1016/j.eururo.2020.03.036.
|
[47] |
ZHANG H, CHEN Y, YUAN Q, et al.Identification of kidney transplant recipients with coronavirus disease 2019[J].Eur Urol, 2020, 77(6): 742-747.DOI: 10.1016/j.eururo.2020.03.030.
|
[48] |
ZHU L, GONG N, LIU B, et al.Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China[J].Eur Urol, 2020, 77(6): 748-754.DOI: 10.1016/j.eururo.2020.03.039.
|
[49] |
WANG Y, YANG H, LIU H, et al.Strategies to halt 2019 novel coronavirus (SARS-CoV-2) spread for organ transplantation programs at the Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, China[J].Am J Transplant, 2020, 20(7): 1837-1839.DOI: 10.1111/ajt.15972.
|
[50] |
XIA S, DUAN K, ZHANG Y, et al.Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials[J].JAMA, 2020, 324(10): 951-960.DOI: 10.1001/jama.2020.15543.
|
[51] |
LAZARUS JV, RATZAN SC, PALAYEW A, et al.A global survey of potential acceptance of a COVID-19 vaccine[J].Nat Med, 2021, 27(2): 225-228.DOI: 10.1038/s41591-020-1124-9.
|